Health Daily News

price with the pharmaceutical industry. I wanted to know if that was one of the tradeoffs for getting this $80 billion was that were not going to pursue that now. MR. GIBBS: Well, look, again, the structure of part of that agreement was to use a portion of that $80 billion to pay up to — for the pharmaceutical industry to pay up to 50 percent of the cost for a name brand drug for a senior that falls between the point at which Medicare Part D stops providing help, and when catastrophic ...